Human Molecular Genetics Advance Access originally published online on August 19, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2003, Vol. 12, Review Issue 2 R239-R248
DOI: 10.1093/hmg/ddg288
© 2003 Oxford University Press
PTEN: tumour suppressor, multifunctional growth regulator and more
Department of Human Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QX, UK
Received June 30, 2003; Accepted August 14, 2003
The tumour suppressor gene PTEN is mutated in a wide range of human cancers at a frequency roughly comparable with p53. In addition, germline PTEN mutations are associated with several dominant growth disorders. The molecular and cellular basis of these disorders has been elucidated by detailed in vivo genetic analysis in model organisms, in particular the fruit fly and mouse. Studies in the fly have shown that PTEN's growth regulatory functions are primarily mediated via its lipid phosphatase activity, which specifically reduces the cellular levels of phosphatidylinositol 3,4,5-trisphosphate. This activity antagonizes the effects of activated PI3-kinase in the nutritionally controlled insulin receptor pathway, thereby reducing protein synthesis and restraining cell and organismal growth, while also regulating other biological processes, such as fertility and ageing. Remarkably, this range of functions appears to be conserved in all higher organisms. PTEN also plays a role as a specialized cytoskeletal regulator, which, for example, is involved in directional movement of some migratory cells and may be important in metastasis. Furthermore, conditional knockouts in the mouse have recently revealed functions for PTEN in other processes, such as cell type specification and cardiac muscle contractility. Genetic approaches have therefore revealed a surprising diversity of global and cell type-specific PTEN-regulated functions that appear to be primarily controlled by modulation of a single phosphoinositide. Together with evidence from studies in cell culture that suggests links between PTEN and other growth regulatory genes such as p53, these studies provide new insights into PTEN-linked disorders and are beginning to suggest potential clinical strategies to combat these and other diseases.
* To whom correspondence should be addressed. Tel: +44 1865282661; Fax: +44 1865272420; Email: deborah.goberdhan{at}anat.ox.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. A. Davis, A. Suryawan, R. A. Orellana, H. V. Nguyen, and M. L. Fiorotto Postnatal ontogeny of skeletal muscle protein synthesis in pigs J Anim Sci, April 1, 2008; 86(14_suppl): E13 - E18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Dave, S. E. Wert, T. Tanner, A. R. Thitoff, D. E. Loudy, and J. A. Whitsett Conditional Deletion of Pten Causes Bronchiolar Hyperplasia Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 337 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Vereshchagina and C. Wilson Cytoplasmic activated protein kinase Akt regulates lipid-droplet accumulation in Drosophila nurse cells Development, December 1, 2006; 133(23): 4731 - 4735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Suryawan, J. Escobar, J. W. Frank, H. V. Nguyen, and T. A. Davis Developmental regulation of the activation of signaling components leading to translation initiation in skeletal muscle of neonatal pigs Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E849 - E859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Huber, O. Distler, I. Tarner, R. E. Gay, S. Gay, and T. Pap Synovial fibroblasts: key players in rheumatoid arthritis Rheumatology, June 1, 2006; 45(6): 669 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nadra, S. I. Anghel, E. Joye, N. S. Tan, S. Basu-Modak, D. Trono, W. Wahli, and B. Desvergne Differentiation of Trophoblast Giant Cells and Their Metabolic Functions Are Dependent on Peroxisome Proliferator-Activated Receptor {beta}/{delta} Mol. Cell. Biol., April 15, 2006; 26(8): 3266 - 3281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sova, Q. Feng, G. Geiss, T. Wood, R. Strauss, V. Rudolf, A. Lieber, and N. Kiviat Discovery of Novel Methylation Biomarkers in Cervical Carcinoma by Global Demethylation and Microarray Analysis Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 114 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Valiente, A. Andres-Pons, B. Gomar, J. Torres, A. Gil, C. Tapparel, S. E. Antonarakis, and R. Pulido Binding of PTEN to Specific PDZ Domains Contributes to PTEN Protein Stability and Phosphorylation by Microtubule-associated Serine/Threonine Kinases J. Biol. Chem., August 12, 2005; 280(32): 28936 - 28943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Phillips, J. Mestas, M. Gharaee-Kermani, M. D. Burdick, A. Sica, J. A. Belperio, M. P. Keane, and R. M. Strieter Epidermal Growth Factor and Hypoxia-induced Expression of CXC Chemokine Receptor 4 on Non-small Cell Lung Cancer Cells Is Regulated by the Phosphatidylinositol 3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and Activation of Hypoxia Inducible Factor-1{alpha} J. Biol. Chem., June 10, 2005; 280(23): 22473 - 22481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. I. Goberdhan, D. Meredith, C. A. R. Boyd, and C. Wilson PAT-related amino acid transporters regulate growth via a novel mechanism that does not require bulk transport of amino acids Development, May 15, 2005; 132(10): 2365 - 2375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shah, W. A. Swain, D. Richardson, J. Edwards, D. J. Stewart, C. M. Richardson, D. E.B. Swinson, D. Patel, J. L. Jones, and K. J. O'Byrne Phospho-Akt Expression Is Associated with a Favorable Outcome in Non-Small Cell Lung Cancer Clin. Cancer Res., April 15, 2005; 11(8): 2930 - 2936. [Abstract] [Full Text] [PDF]
|
|